Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Victor, R. Larisa, Y. Marina, K. Lev, E. Putova (Moscow, Russian Federation). Drug resistance among new TB cases and relapses. Eur Respir J 2011; 38: Suppl. 55, 2620

Member's Comments

No comment yet.

Related content which might interest you: Drug resistance rates in soldier patients newly diagnosed with TB Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008 Drug resistant TB treatment outcomes in Novokuznetsk Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007 Drug resistance in tuberculosis Source: Eur Respir J 2005; 25: 376-379 Year: 2005 Drug resistant tuberculosis in hospitalized patients Source: Eur Respir J 2006; 28: Suppl. 50, 10s Year: 2006 Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009 Drug resistance pattern of directly observed treatment shortcourse (DOTS) category-II relapse patients Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011 Antituberculous drug resistance rates in soldier patients newly diagnosed with TB in Turkey Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Antituberculosis drug resistance rates in patients newly diagnosed with TB in Istanbul Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003 Drug resistance and tuberculosis elimination in low-incidence countries Source: Eur Respir J 2014; 44: 1408-1411 Year: 2014 Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Treatment outcomes of new cases of polyresistant pulmonary TB with second line anti-TB drugs in DOTS-Plus regimen Source: Eur Respir J 2002; 20: Suppl. 38, 359s Year: 2002 The relapses of tuberculosis with multiple drug resistance among patients treated under DOTS-Plus regimen Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Medico-social features of resistance development to new anti–TB drugs in patients with MDR/XDR TB Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021 Drug resistance in pulmonary TB patients: Analysis of dynamics Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Preventing MDRTB in Europe: Drug sensitivities received after the initial phase of treatment Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Drug resistance in previously treated patients of tuberculosis in pre DOTS and DOTS era and its implications Source: Annual Congress 2009 - Tuberculosis control Year: 2009 Resistance to second-line anti-tuberculosis drugs: new drug resistant TB treatment problem Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis Year: 2007